The only value I’m hoping is for RecoveryRx to b
Post# of 7786
The players are in place for this to hopefully happen. I can’t see Kelly going alone to market BEIL
Current sales and 25 billion outstanding does not concern me one bit.
We already know that they have a $50.00 target price for RecoveryRx. That 25 billion outstanding shares will be chicken feed compared to the Billions of $$$$ revenues that can be generated.
Viant knows what BIELS has and that is why Sree made the move to Viant.
My gut feeling there is a plan in place, I could be wrong
Sometimes you have to read between the lines.
Why did Paul K mistakenly send a email about a company being sold? Why is a lawyer and not a tax accountant after filing 2 extensions looking over tax returns.
Making sure that all the T’ s are crossed and all the dots are dotted are done for contract agreements.
I could be reading to much into it, but just trying to be hopeful.
JMHO !!
All the best to you my friend.
Zattnt